| Literature DB >> 33269918 |
Michele F Sciacca1, Fabio Lolicato2,3, Carmelo Tempra4,5, Federica Scollo5,6, Bikash R Sahoo7, Matthew D Watson8, Sara García-Viñuales1, Danilo Milardi1, Antonio Raudino5, Jennifer C Lee8, Ayyalusamy Ramamoorthy7, Carmelo La Rosa5.
Abstract
An increasing number of human diseases has been shown to be linked to aggregation and amyloid formation by intrinsically disordered proteins (IDPs). Amylin, amyloid-β, and α-synuclein are, indeed, involved in type-II diabetes, Alzheimer's, and Parkinson's, respectively. Despite the correlation of the toxicity of these proteins at early aggregation stages with membrane damage, the molecular events underlying the process is quite complex to understand. In this study, we demonstrate the crucial role of free lipids in the formation of lipid-protein complex, which enables an easy membrane insertion for amylin, amyloid-β, and α-synuclein. Experimental results from a variety of biophysical methods and molecular dynamics results reveal that this common molecular pathway in membrane poration is shared by amyloidogenic (amylin, amyloid-β, and α-synuclein) and nonamyloidogenic (rat IAPP, β-synuclein) proteins. Based on these results, we propose a "lipid-chaperone" hypothesis as a unifying framework for protein-membrane poration.Entities:
Keywords: Alzheimer; Intrinsically disordered proteins; Parkinson; diabetes mellitus; lipid-chaperone hypothesis; oxidized lipids
Mesh:
Substances:
Year: 2020 PMID: 33269918 PMCID: PMC7769131 DOI: 10.1021/acschemneuro.0c00588
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418